A multi-centre phase IIa clinical study of predictive testing for preeclampsia: improved pregnancy outcomes via early detection (IMPROvED)

BACKGROUND: 5% of first time pregnancies are complicated by pre-eclampsia, the leading cause of maternal death in Europe. No clinically useful screening test exists; consequentially clinicians are unable to offer targeted surveillance or preventative strategies. IMPROvED Consortium members have pion...

Descripción completa

Detalles Bibliográficos
Autores principales: Navaratnam, Kate, Alfirevic, Zarko, Baker, Philip N, Gluud, Christian, Grüttner, Berthold, Kublickiene, Karolina, Zeeman, Gerda, Kenny, Louise C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029471/
https://www.ncbi.nlm.nih.gov/pubmed/24314209
http://dx.doi.org/10.1186/1471-2393-13-226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029471/
https://www.ncbi.nlm.nih.gov/pubmed/24314209
http://dx.doi.org/10.1186/1471-2393-13-226

Ejemplares similares